MILESTONE PHARMACEUTICALS IN (MIST) Stock Cash Flow
NASDAQ:MIST - Nasdaq - CA59935V1076 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -41.52M | -59.69M | -58.39M | -42.85M | -49.97M | |||
| Depreciation Amortization | 105.00K | 92.00K | 90.00K | 90.00K | 100.00K | |||
| Change In Working Capital | 3.66M | 1.24M | -3.26M | 2.26M | -5.81M | |||
| Other non cash items | 8.91M | 11.93M | 9.09M | 7.28M | 4.95M | |||
| OPERATING CASH FLOW | -28.85M | -46.42M | -52.47M | -33.22M | -50.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -33.00K | -112.00K | -270.00K | N/A | N/A | |||
| Other Investing Activity | 8.32M | 4.87M | -56.85M | 70.00M | -70.00M | |||
| INVESTING CASH FLOW | 8.28M | 4.76M | -57.12M | 70.00M | -70.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 50.00M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 27.50M | 582.00K | 3.09M | 5.06M | 73.22M | |||
| Other Financing Activity | 4.62M | -2.79M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 32.12M | 47.79M | 3.09M | 5.06M | 73.22M | |||
| CHANGE IN CASH | 11.55M | 6.12M | -106.50M | 41.84M | -47.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.85M | -46.42M | -52.47M | -33.22M | -50.73M | |||
| Capital Expenditure | -33.00K | -112.00K | -270.00K | N/A | N/A | |||
| FREE CASH FLOW | -28.88M | -46.54M | -52.74M | -33.22M | -50.73M | |||
All data in USD